Identification of an outer membrane lipoprotein involved in nasopharyngeal colonization by Moraxella catarrhalis in an animal model

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2287-2299

  Wang, Wei ^a   Joslin, Stephanie N ^b   Pybus, Christine ^b   Evans, Amanda S ^b   Lichaa, Flora ^a   Brautigam, Chad A ^c   Hansen, Eric J ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GLOBOMYCIN; MEMBRANE PROTEIN; ORF113 PROTEIN; OUTER MEMBRANE PROTEIN A; PEPTIDOGLYCAN; SIGNAL PEPTIDASE II; UNCLASSIFIED DRUG; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN; PEPTIDE; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL SURFACE; CHINCHILLA; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; IN VITRO STUDY; MORAXELLA CATARRHALIS; MORAXELLACEAE INFECTION; NASOPHARYNX; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; RHINOPHARYNGITIS; UPREGULATION; ANIMAL; BACTERIUM ADHERENCE; CELL LINE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; PHARYNX DISEASE; PHYSIOLOGY;

ANIMALS; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; CHINCHILLA; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; NASOPHARYNGEAL DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PROTEASE INHIBITORS;

EID: 84900385659     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01745-14     Document Type: Article

References (81)

1. Murphy TF. 2005. Moraxella (Branhamella) catarrhalis and other gramnegative cocci, p 2529. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious disease, 6th ed. Elsevier Inc, Philadelphia, PA.
2. Karalus R, Campagnari A. 2000. Moraxella catarrhalis: a review of an mportant human mucosal pathogen. Microbes Infect. 2:547-559. http://dx.doi.org/10.1016/S1286-4579(00)00314-2.
3. Murphy TF. 2000. Bacterial otitis media: pathogenetic considerations. Pediatr. Infect. Dis. J. 19:S9-S15. http://dx.doi.org/10.1097/00006454-200005001-00003.
4. Verduin CM, Hol C, Fleer A, van Dijk H, Van Belkum A. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 15:125-144. http://dx.doi.org/10.1128/CMR.15.1.125-144.2002.
5. Murphy TF. 1996. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:267-279.
6. Murphy TF, Brauer AL, Grant BJ, Sethi S. 2005. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am. J. Respir. Crit. Care Med. 172:195-199. http://dx.doi.org/10.1164/rccm.200412-1747OC.
7. Sethi S, Evans N, Grant BJ, Murphy TF. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471. http://dx.doi.org/10.1056/NEJMoa012561.
8. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R. 2006. Epidemiology and costs of chronic obstructive pulmonary disease. Eur. Respir. J. 27:188-207. http://dx.doi.org/10.1183/09031936.06.00024505.
9. Murphy TF, Parameswaran GI. 2009. Moraxella catarrhalis, a human respiratory tract pathogen. Clin. Infect. Dis. 49:124-131. http://dx.doi.org/10.1086/599375.
10. Faden HS, Harabuchi Y, Hong JJ, Pediatrics TW. 1994. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J. Infect. Dis. 169:1312-1317. http://dx.doi.org/10.1093/infdis/169.6.1312.
11. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE. 2006. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296:202-211. http://dx.doi.org/10.1001/jama.296.2.202.
12. Hoa M, Tomovic S, Nistico L, Hall-Stoodley L, Stoodley P, Sachdeva L, Berk R, Coticchia JM. 2009. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Int. J. Pediatr. Otorhinolaryngol. 73:1242-1248. http://dx.doi.org/10.1016/j.ijporl.2009.05.016.
13. Forsgren A, Brant M, Karamehmedovic M, Riesbeck K. 2003. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect. Immun. 71:3302-3309. http://dx.doi.org/10.1128/IAI.71.6.3302-3309.2003.
14. Holm MM, Vanlerberg SL, Sledjeski DD, Lafontaine ER. 2003. The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect. Immun. 71:4977-4984. http://dx.doi.org/10.1128/IAI.71.9.4977-4984.2003.
15. Lafontaine ER, Cope LD, Aebi C, Latimer JL, McCracken GH, Jr, Hansen EJ. 2000. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J. Bacteriol. 182:1364-1373. http://dx.doi.org/10.1128/JB.182.5.1364-1373.2000.
16. Reddy MS, Murphy TF, Faden HS, Bernstein JM. 1997. Middle ear mucin glycoprotein; purification and interaction with nontypeable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol. Head Neck Surg. 116:175-180. http://dx.doi.org/10.1016/S0194-5998(97)70321-8.
17. Holm MM, Vanlerberg SL, Foley IM, Sledjeski DD, Lafontaine ER. 2004. The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect. Immun. 72:1906-1913. http://dx.doi.org/10.1128/IAI.72.4.1906-1913.2004.
18. Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. 2007. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect. Immun. 75:5559-5564. http://dx.doi.org/10.1128/IAI.00946-07.
19. Lipski SL, Akimana C, Timpe JM, Wooten RM, Lafontaine ER. 2007. The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its Nterminal passenger domain. Infect. Immun. 75:314-324. http://dx.doi.org/10.1128/IAI.01330-06.
20. Plamondon P, Luke NR, Campagnari AA. 2007. Identification of a novel two-partner secretion locus in Moraxella catarrhalis. Infect. Immun. 75: 2929-2936. http://dx.doi.org/10.1128/IAI.00396-07.
21. Lafontaine ER, Wagner NJ, Hansen EJ. 2001. Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level. J. Bacteriol. 183:1540-1551. http://dx.doi.org/10.1128/JB.183.5.1540-1551.2001.
22. Pearson MM, Lafontaine ER, Wagner NJ, St Geme JW, III, Hansen EJ. 2002. A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect. Immun. 70:4523-4533. http://dx.doi.org/10.1128/IAI.70.8.4523-4533.2002.
23. Wang W, Pearson MM, Attia AS, Blick RJ, Hansen EJ. 2007. A UspA2Hnegative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes. Infect. Immun. 75:2035-2045. http://dx.doi.org/10.1128/IAI.00609-06.
24. Möllenkvist A, Nordstrom T, Hallden C, Christensen JJ, Forsgren A, Riesbeck K. 2003. The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation. J. Bacteriol. 185:2285-2295. http://dx.doi.org/10.1128/JB.185.7.2285-2295.2003.
25. Seib KL, Peak IRA, Jennings MP. 2002. Phase variable restriction-modification systems in Moraxella catarrhalis. FEMS Immunol. Med. Microbiol. 32: 159-165. http://dx.doi.org/10.1111/j.1574-695X.2002.tb00548.x.
26. Attia AS, Hansen EJ. 2006. A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein. J. Bacteriol. 188:7840-7852. http://dx.doi.org/10.1128/JB.01204-06.
27. Furano K, Campagnari AA. 2003. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infect. Immun. 71:1843-1848. http://dx.doi.org/10.1128/IAI.71.4.1843-1848.2003.
28. Heiniger N, Troller R, Meier PS, Aebi C. 2005. Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis. Infect. Immun. 73: 8247-8255. http://dx.doi.org/10.1128/IAI.73.12.8247-8255.2005.
29. Jetter M, Spaniol V, Troller R, Aebi C. 2010. Down-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillins. J. Antimicrob. Chemother. 65:2089-2096. http://dx.doi.org/10.1093/jac/dkq312.
30. Spaniol V, Troller R, Schaller A, Aebi C. 2011. Physiologic cold shock of Moraxella catarrhalis affects the expression of genes involved in the iron acquisition, serum resistance and immune evasion. BMC Microbiol. 11:182. http://dx.doi.org/10.1186/1471-2180-11-182.
31. Wang W, Reitzer L, Rasko DA, Pearson MM, Blick RJ, Laurence C, Hansen EJ. 2007. Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression. Infect. Immun. 75:4959-4971. http://dx.doi.org/10.1128/IAI.00073-07.
32. Hoopman TC, Liu W, Joslin SN, Pybus C, Sedillo JL, Labandeira-Rey M, Laurence CA, Wang W, Richardson JA, Bakaletz LO, Hansen EJ. 2012. Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis. Infect. Immun. 80:982-995. http://dx.doi.org/10.1128/IAI.05918-11.
33. Murphy TF, Loeb MR. 1989. Isolation of the outer membrane of Branhamella catarrhalis. Microb. Pathog. 6:159-174. http://dx.doi.org/10.1016/0882-4010(89)90066-1.
34. Helminen ME, Maciver I, Latimer JL, Cope LD, McCracken GH, Jr, Hansen EJ. 1993. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010.
35. Hoopman TC, Liu W, Joslin SN, Pybus C, Brautigam CA, Hansen EJ. 2011. Identification of gene products involved in the oxidative stress response of Moraxella catarrhalis. Infect. Immun. 79:745-755. http://dx.doi.org/10.1128/IAI.01060-10.
36. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng Finkbeiner KWE, Widdicombe JH, Gruenert DC. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:38-47. http://dx.doi.org/10.1165/ajrcmb.10.1.7507342.
37. Aebi C, Lafontaine ER, Cope LD, Latimer JL, Lumbley SR, McCracken GH, Jr, Hansen EJ. 1998. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis O35E. Infect. Immun. 66:3113-3119.
38. Fay MP, Proschan MA. 2010. Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat. Surv. 4:1-39. http://dx.doi.org/10.1214/09-SS051.
39. Bechhofer DH, Oussenko IA, Deikus G, Yao S, Mathy N, Condon C. 2008. Analysis of mRNA decay in Bacillus subtilis. Methods Enzymol. 447: 259-276. http://dx.doi.org/10.1016/S0076-6879(08)02214-3.
40. Bechhofer DH, Wang W. 1998. Decay of ermC mRNA in a polynucle-otide phosphorylase mutant of Bacillus subtilis. J. Bacteriol. 180:5968-5977.
41. Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J, Ratti G, Petracca R, Galli G, Agnusdei M, Giuliani MM, Santini L, Brunelli B, Tettelin H, Rappuoli R, Randazzo F, Grandi G. 2002. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat. Biotechnol. 20:914-921. http://dx.doi.org/10.1038/nbt728.
42. Slevogt H, Seybold J, Tiwari KN, Hocke AC, Jonatat C, Dietel S, Hippenstiel S, Singer BB, Bachmann S, Suttorp N, Opitz B. 2007. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2-and partly NOD1-dependent inflammatory immune response. Cell. Microbiol. 9:694-707. http://dx.doi.org/10.1111/j.1462-5822.2006.00821.x.
43. Hand WL, King-Thompson N, Holman JW. 1987. Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 31:1553-1557. http://dx.doi.org/10.1128/AAC.31.10.1553.
44. Horton RM, Cai Z, Ho SN, Pease LR. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8:528-535.
45. Wang W, Hansen EJ. 2006. Plasmid pWW115, a cloning vector for use with Moraxella catarrhalis. Plasmid 56:133-137. http://dx.doi.org/10.1016/j.plasmid.2006.03.002.
46. Weinrauch Y, Msadek T, Kunst F, Dubnau D. 1991. Sequence and properties of comQ, a new competence regulatory gene of Bacillus subtilis. J. Bacteriol. 173:5685-5693.
47. Whitley E, Ball J. 2002. Statistics review 6: nonparametric methods. Crit. Care 6:509-513. http://dx.doi.org/10.1186/cc1820.
48. Murphy TF, Brauer AL, Yuskiw N, McNamara ER, Kirkham C. 2001. Conservation of outer membrane protein E among strains of Moraxella catarrhalis. Infect. Immun. 69:3576-3580. http://dx.doi.org/10.1128/IAI.69.6.3576-3580.2001.
49. Bhushan R, Craige R, Murphy TF. 1994. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J. Bacteriol. 176:6636-6643.
50. Bhushan R, Kirkham C, Sethi S, Murphy TF. 1997. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Infect. Immun. 65:2668-2675.
51. Murphy TF, Brauer AL, Yuskiw N, Hiltke TJ. 2000. Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants. Infect. Immun. 68:6250-6256. http://dx.doi.org/10.1128/IAI.68.11.6250-6256.2000.
52. Davie JJ, Earl J, de Vries SP, Ahmed A, Hu FZ, Bootsma HJ, Stol K, Hermans PW, Wadowsky RM, Ehrlich GD, Hays JP, Campagnari AA. 2011. Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates. BMC Genomics 12:70. http://dx.doi.org/10.1186/1471-2164-12-70.
53. de Vries SP, van Hijum SA, Schueler W, Riesbeck K, Hays JP, Hermans PW, Bootsma HJ. 2010. Genome analysis of Moraxella catarrhalis strain RH4, a human respiratory tract pathogen. J. Bacteriol. 192:3574-3583. http://dx.doi.org/10.1128/JB.00121-10.
54. Hussain M, Ichibara S, Mizushima S. 1980. Accumulation of glyceridecontaining precursor of the outer membrane lipoprotein in the cytoplasmic membrane of Escherichia coli treated with globomycin. J. Biol. Chem. 255:3707-3712.
55. Grizot S, Buchanan SK. 2004. Structure of the OmpA-like domain of RmpM from Neisseria meningitidis. Mol. Microbiol. 51:1027-1037. http://dx.doi.org/10.1111/j.1365-2958.2003.03903.x.
56. Parsons LM, Lin F, Orban J. 2006. Peptidoglycan recognition by Pal, an outer membrane lipoprotein. Biochemistry 45:2122-2128. http://dx.doi.org/10.1021/bi052227i.
57. Roujeinikova A. 2008. Crystal structure of the cell wall anchor domain of MotB, a stator component of the bacterial flagellar motor: implications for peptidoglycan recognition. Proc. Natl. Acad. Sci. U. S. A. 105:10348-10353. http://dx.doi.org/10.1073/pnas.0803039105.
58. Pei J, Kim BH, Grishin NV. 2008. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res. 36:2295-2300. http://dx.doi.org/10.1093/nar/gkn072.
59. Bakaletz LO, Murwin DM, Billy JM. 1995. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect. Immun. 63:4188-4190.
60. Fink J, Mathaba LT, Stewart GA, Graham PT, Steer JH, Joyce DA, McWilliam AS. 2006. Moraxella catarrhalis stimulates the release of proinflammatory cytokines and prostaglandin E from human respiratory epithelial cells and monocyte-derived macrophages. FEMS Immunol. Med. Microbiol. 46: 198-208. http://dx.doi.org/10.1111/j.1574-695X.2005.00022.x.
61. Rosseau S, Wiechmann K, Moderer S, Selhorst J, Mayer K, Krull M, Hocke A, Slevogt H, Seeger W, Suttorp N, Seybold J, Lohmeyer J. 2005. Moraxella catarrhalis-infected alveolar epithelium induced monocyte recruitment and oxidative burst. Am. J. Respir. Cell Mol. Biol. 32:157-166. http://dx.doi.org/10.1165/rcmb.2004-0091OC.
62. Mocca B, Wang W. 2012. Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro. J. Bacteriol. 194:4059-4068. http://dx.doi.org/10.1128/JB.00476-12.
63. Spaniol V, Heiniger N, Troller R, Aebi C. 2008. Outer membrane protein UspA1 and lipooligosaccharide are involved in invasion of human epithelial cells by Moraxella catarrhalis. Microbes Infect. 10:3-11. http://dx.doi.org/10.1016/j.micinf.2007.09.014.
64. Heiniger N, Spaniol V, Troller R, Vischer M, Aebi C. 2007. A reservoir of Moraxella catarrhalis in human pharyngeal lymphoid tissue. J. Infect. Dis. 196:1080-1087. http://dx.doi.org/10.1086/521194.
65. Vallis AJ, Yahr TL, Barbieri JT, Frank DW. 1999. Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions. Infect. Immun. 67:914-920.
66. Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, Hwang SH, Hassett DJ, Schurr MJ. 2004. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect. Immun. 72:5433-5438. http://dx.doi.org/10.1128/IAI.72.9.5433-5438.2004.
67. Kim N, Marcus EA, Wen Y, Weeks DL, Scott DR, Jung HC, Song IS, Sachs G. 2004. Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect. Immun. 72:2358-2368. http://dx.doi.org/10.1128/IAI.72.4.2358-2368.2004.
68. Boekema BK, van Putten JP, Stockhofe-Zurwieden N, Smith HE. 2004. Host cell contact-induced transcription of the type IV fimbria gene cluster of Actinobacillus pleuropneumoniae. Infect. Immun. 72:691-700. http://dx.doi.org/10.1128/IAI.72.2.691-700.2004.
69. Du Y, Lenz J, Arvidson CG. 2005. Global gene expression and the role of sigma factors in Neisseria gonorrhoeae in interactions with epithelial cells. Infect. Immun. 73:4834-4845. http://dx.doi.org/10.1128/IAI.73.8.4834-4845.2005.
70. Dietrich G, Kurz S, Hubner C, Aepinus C, Theiss S, Guckenberger M, Panzner U, Weber J, Frosch M. 2003. Transcriptome analysis of Neisseria meningitidis during infection. J. Bacteriol. 185:155-164. http://dx.doi.org/10.1128/JB.185.1.155-164.2003.
71. Deghmane AE, Giorgini D, Larribe M, Alonso JM, Taha MK. 2002. Downregulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol. Microbiol. 43:1555-1564. http://dx.doi.org/10.1046/j.1365-2958.2002.02838.x.
72. Wang W, Richardson AR, Martens-Habbena W, Stahl DA, Fang FC, Hansen EJ. 2008. Identification of a repressor of a truncated denitrification pathway in Moraxella catarrhalis. J. Bacteriol. 190:7762-7772. http://dx.doi.org/10.1128/JB.01032-08.
73. de Vries SP, Eleveld MJ, Hermans PW, Bootsma HJ. 2013. Characterization of the molecular interplay between Moraxella catarrhalis and human respiratory tract epithelial cells. PLoS One 8:e72193. http://dx.doi.org/10.1371/journal.pone.0072193.
74. Adlowitz DG, Hiltke T, Lesse AJ, Murphy TF. 2004. Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis. Vaccine 22:2533-2540. http://dx.doi.org/10.1016/j.vaccine.2003.12.016.
75. Adlowitz DG, Sethi S, Cullen P, Adler B, Murphy TF. 2005. Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis. Infect. Immun. 73:6601-6607. http://dx.doi.org/10.1128/IAI.73.10.6601-6607.2005.
76. Kovacs-Simon A, Titball RW, Michell SL. 2011. Lipoproteins of bacterial pathogens. Infect. Immun. 79:548-561. http://dx.doi.org/10.1128/IAI.00682-10.
77. Llobet E, March C, Gimenez P, Bengoechea JA. 2009. Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob. Agents Chemother. 53:298-302. http://dx.doi.org/10.1128/AAC.00657-08.
78. Serino L, Nesta B, Leuzzi R, Fontana MR, Monaci E, Mocca BT, Cartocci E, Masignani V, Jerse AE, Rappuoli R, Pizza M. 2007. Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Mol. Microbiol. 64:1391-1403. http://dx.doi.org/10.1111/j.1365-2958.2007.05745.x.
79. Armbruster CE, Hong W, Pang B, Weimer KE, Juneau RA, Turner J, Swords WE. 2010. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio 1(3):e00102-10. http://dx.doi.org/10.1128/mBio.00102-10.
80. Verhaegh SJ, Snippe ML, Levy F, Verbrugh HA, Jaddoe VW, Hofman A, Moll HA, van Belkum A, Hays JP. 2011. Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae. Microbiology 157:169-178. http://dx.doi.org/10.1099/mic.0.042929-0.
81. Pearson MM, Hansen EJ. 2007. Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro. Infect. Immun. 75:4316-4325. http://dx.doi.org/10.1128/IAI.01347-06.